Alembic Pharmaceuticals
- Revenue₹52.8 BFY, 2021
- Market Capitalization₹148.4 B2022-05-20
OverviewSuggest Edit
| Type | Public | |
| Founded | 1907 | |
| HQ | Vadodara, IN | Map |
| Website | alembicpharmaceuticals.com |
Key People/Management at Alembic Pharmaceuticals
Chirayu Amin
Pranav Amin
Shaunak Amin
R. K. Baheti
K. G. Ramanathan
Pranav Parikh
Alembic Pharmaceuticals Office Locations
Alembic Pharmaceuticals Financials and Metrics
Alembic Pharmaceuticals Revenue
| INR | |
|---|---|
Revenue (Q3, 2022) | 12.7b |
Gross profit (Q3, 2022) | 9.3b |
Net income (Q3, 2022) | 1.6b |
EBITDA (Q3, 2022) | 2.6b |
EBIT (Q3, 2022) | 2.0b |
Market capitalization (20-May-2022) | 148.4b |
Closing stock price (20-May-2022) | 753.5 |
Cash (31-Mar-2022) | 694.3m |
EV | 154.8b |
| INR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|---|
Revenue | 31.2b | 39.3b | 45.9b | 52.8b |
Cost of goods sold | (10.4b) | (11.7b) | (13.0b) | (15.0b) |
Gross profit | 20.9b | 27.6b | 33.1b | 39.0b |
R&D expense | (3.9b) | (302.7m) | (426.4m) | (253.8m) |
| INR | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 | Q2, 2022 | Q3, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 8.6b | 11.3b | 10.2b | 9.5b | 12.4b | 12.1b | 13.4b | 14.6b | 13.1b | 13.3b | 12.9b | 12.7b |
Cost of goods sold | (2.6b) | (2.7b) | (2.5b) | (2.0b) | (2.7b) | (3.0b) | (3.4b) | (3.1b) | (2.9b) | (3.9b) | (3.3b) | (3.4b) |
Gross profit | 6.1b | 8.6b | 7.7b | 7.5b | 9.7b | 9.1b | 10.0b | 11.5b | 10.2b | 9.4b | 9.6b | 9.3b |
R&D expense | (1.2b) | (1.4b) | (1.1b) | (1.4b) | (1.3b) | (1.4b) | (1.8b) | (1.5b) | (1.7b) | (1.7b) | (1.5b) |
| INR | FY, 2018 | FY, 2022 |
|---|---|---|
Cash | 899.2m | 694.3m |
Accounts Receivable | 5.3b | 8.1b |
Prepaid Expenses | 1.7b | 250.8m |
Inventories | 7.3b | 16.1b |
| INR | FY, 2018 | FY, 2022 |
|---|---|---|
Net Income | 5.4b | 6.2b |
Depreciation and Amortization | 1.1b | 2.9b |
Inventories | (1.0b) | (1.2b) |
Accounts Payable | 2.6b | 366.7m |
Alembic Pharmaceuticals Revenue Breakdown
Alembic Pharmaceuticals revenue breakdown by business segment: 100.0% from MANUFACTURE OF PHARMACEUTICALS
Alembic Pharmaceuticals Cybersecurity Score
Alembic Pharmaceuticals Environment, Social & Governance (ESG) Ratings
Alembic Pharmaceuticals Online and Social Media Presence
82 Twitter followers
Alembic Pharmaceuticals has 82 Twitter Followers. The number of followers has increased 2.2% month over month and increased 8% quarter over quarter
Alembic Pharmaceuticals's Trends
Alembic Pharmaceuticals News and Updates
Spasticity Treatment Market - 41% of Growth to Originate from North America| Evolving Opportunities with Allergan Plc & Alembic Pharmaceuticals Ltd. | Technavio
Alembic Pharmaceuticals Frequently Asked Questions
When was Alembic Pharmaceuticals founded?
Alembic Pharmaceuticals was founded in 1907.
Who are Alembic Pharmaceuticals key executives?
Alembic Pharmaceuticals's key executives are Chirayu Amin, Pranav Amin and Shaunak Amin.
How many employees does Alembic Pharmaceuticals have?
Alembic Pharmaceuticals has 12,160 employees.
What is Alembic Pharmaceuticals revenue?
Latest Alembic Pharmaceuticals annual revenue is ₹52.8 b.
What is Alembic Pharmaceuticals revenue per employee?
Latest Alembic Pharmaceuticals revenue per employee is ₹4.3 m.
Who are Alembic Pharmaceuticals competitors?
Competitors of Alembic Pharmaceuticals include YiChang HEC ChangJiang Pharmaceutical, Noven Pharmaceuticals and Ferrer.
Where is Alembic Pharmaceuticals headquarters?
Alembic Pharmaceuticals headquarters is located at Alembic Rd, Gorwa, Vadodara.
Where are Alembic Pharmaceuticals offices?
Alembic Pharmaceuticals has offices in Vadodara and Mumbai.
How many offices does Alembic Pharmaceuticals have?
Alembic Pharmaceuticals has 3 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies